Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

13.21 13.96 12.45 17.19
P/S ratio
0.37 0.39 0.32 0.42
P/FCF ratio
19.15 24.74 9.98 13.34
P/Operating CF
63.57 934.80 14.85 43.87
P/B ratio
1.64 1.78 1.46 1.86
EV/Sales
0.35 0.37 0.29 0.39
EV/EBITDA
6.78 7.69 6.38 8.79
EV/FCF
18.01 23.41 9.05 12.32
Current Ratio
1.56 1.54 1.48 1.52
Net Debt/EBITDA
(2.00) (4.27) (1.98) (2.43)
Debt/Equity
0.72 0.72 0.71 0.69
Earnings Yield
7.57% 7.17% 8.03% 5.82%
Free Cash Flow Yield
5.22% 4.04% 10.02% 7.49%
Free Cash Flow per Share
3.47 (0.93) 18.64 7.49
Book value per Share
197.41 196.54 200.37 207.47
Free Cash Flow
775.00 (209.00) 4,097.00 1,626.00
EV/EBIT
8.01 9.16 7.65 10.61
Other line items

Show all line items

Columns are period end dates